Articles

Alzheimer’s tests present dilemma of knowing the future

While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.

Read More

Covance shareholder sues over $6.1B LabCorp deal

A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.

Read More

Avanir’s Takeover Price Leaves Room for Counteroffers

Avanir Pharmaceuticals Inc. has reached a The Aliso Viejo, California-based company, which makes a drug to control symptoms of Alzheimer’s disease, this week agreed to sell itself to Japan’s Otsuka Holdings Co. for $3.2 billion, or $17 a share. That’s 4 percent lower than analysts’ average projection for where the stock would have traded in […]

Read More

New type of cholesterol drug shows promise in study

The results have immediate implications for 1 million Americans who suffer mild heart attacks or chest pain each year. They may also make it easier for other experimental medicines from companies such as Eli Lilly to reach patients.

Read More
A&E

Dead celebrities show promotional staying power

With help from companies like Indianapolis-based CMG Worldwide, deceased icons like James Dean, Michael Jackson, Elvis Presley and Amelia Earhart are enjoying unprecedented success, out-earning even their former flesh-and-blood selves.

Read More